GB0702537D0 - Treatment for excessive adiposity - Google Patents

Treatment for excessive adiposity

Info

Publication number
GB0702537D0
GB0702537D0 GB0702537A GB0702537A GB0702537D0 GB 0702537 D0 GB0702537 D0 GB 0702537D0 GB 0702537 A GB0702537 A GB 0702537A GB 0702537 A GB0702537 A GB 0702537A GB 0702537 D0 GB0702537 D0 GB 0702537D0
Authority
GB
United Kingdom
Prior art keywords
treatment
excessive adiposity
adiposity
excessive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0702537A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Original Assignee
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Universiteit Leuven filed Critical Katholieke Universiteit Leuven
Priority to GB0702537A priority Critical patent/GB0702537D0/en
Publication of GB0702537D0 publication Critical patent/GB0702537D0/en
Priority to PCT/BE2008/000005 priority patent/WO2008098318A1/en
Ceased legal-status Critical Current

Links

GB0702537A 2007-02-12 2007-02-12 Treatment for excessive adiposity Ceased GB0702537D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0702537A GB0702537D0 (en) 2007-02-12 2007-02-12 Treatment for excessive adiposity
PCT/BE2008/000005 WO2008098318A1 (en) 2007-02-12 2008-02-01 Treatment and medication to reduce body adiposity with low-dose pioglitazone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0702537A GB0702537D0 (en) 2007-02-12 2007-02-12 Treatment for excessive adiposity

Publications (1)

Publication Number Publication Date
GB0702537D0 true GB0702537D0 (en) 2007-03-21

Family

ID=37899050

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0702537A Ceased GB0702537D0 (en) 2007-02-12 2007-02-12 Treatment for excessive adiposity

Country Status (2)

Country Link
GB (1) GB0702537D0 (en)
WO (1) WO2008098318A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007058842A1 (en) * 2007-12-05 2009-06-10 Grünenthal GmbH drug
US8846315B2 (en) 2008-08-12 2014-09-30 Zinfandel Pharmaceuticals, Inc. Disease risk factors and methods of use
US8815508B2 (en) 2008-08-12 2014-08-26 Zinfandel Pharmaceuticals, Inc. Method of identifying disease risk factors
EA201691399A1 (en) 2011-01-10 2016-10-31 Зинфандел Фармасьютикалз, Инк. METHODS AND READY MEDICATION FORMS FOR THE TREATMENT OF ALZHEYMER
GB201518979D0 (en) * 2015-10-27 2015-12-09 Univ Leuven Kath Treatment of hepatic steatosis related oligo-ovulation
CN106511354A (en) * 2017-01-18 2017-03-22 刘�英 Application of pioglitazone-containing pharmaceutical composition in diabetes prevention

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646169A (en) * 1987-09-04 1997-07-08 Beecham Group P.L.C. Compounds for treating eating disorders in which blood glucose levels are raised
US6121288A (en) * 1996-11-08 2000-09-19 Nippon Chemiphar Co., Ltd. Visceral fat lowering agent
US20030064950A1 (en) * 2001-02-23 2003-04-03 Ntambi James M. Methods for reducing body fat and increasing lean body mass by reducing stearoyl-CoA desaturase 1 activity

Also Published As

Publication number Publication date
WO2008098318A1 (en) 2008-08-21

Similar Documents

Publication Publication Date Title
EP2106814A4 (en) Treatment device
GB0714363D0 (en) Treatment apparatus
EP2320907A4 (en) Therapeutic compounds
IL206654A0 (en) Combination therapy
IL213619A0 (en) Treatment
GB0802116D0 (en) Treatment
EP2175873A4 (en) Treatment for anxiety
EP2268285A4 (en) Therapeutic compounds
IL199992A0 (en) Combination therapy
GB0822011D0 (en) Treatment
GB0806794D0 (en) Therapeutic compounds
GB0711342D0 (en) Well treatment
GB0807850D0 (en) Treatment device
GB0719518D0 (en) Therapy
GB0804755D0 (en) Therapeutic compounds
GB0811992D0 (en) Treatment
GB0702537D0 (en) Treatment for excessive adiposity
EP2174956A4 (en) Compositions for anti-fibrinolitic treatment
EP2182884A4 (en) Treatment apparatus
EP2211863A4 (en) Combination therapy
GB0716784D0 (en) Well treatment
EP2240192A4 (en) Treatment for dermatological conditions
EP2133035A4 (en) Treatment device
GB0700284D0 (en) Combination therapy
IL207906A0 (en) Treatment for ocular-related disorders

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)